亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台，協助業界發掘知識產權貿易商機，並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權，或是製造商需要購買技術以提高操作效能，又或是知識產權配套服務供應商，你將會從本網站發掘到有用的知識產權貿易資訊。

返回搜索結果

Monoclonal Antibodies Against Chk2 (Clone 4B8)

技術優勢: Specific antibody to detect Chk2 by antibody-antigen complex formation.

技術應用: Immunoprecipitation Western blot

詳細技術說明: Chk2 is a member of the CDS1 subfamily of serine/threonine protein kinases. Chk2 is a cell cycle checkpoint regulator and putative tumor suppressor. A forkhead-associated protein interaction domain is critical for activation in response to DNA damage and is rapidly phosphorylated in response to replication blocks and DNA damage. Once activated, Chk2 inhibits CDC25C phosphatase, preventing mitosis, and has been shown to stabilize the tumor suppressor protein p53. Chk2 also interacts and phosphorylates BRCA1 to promote cell survival after DNA damage. Mutations in Chk2 are linked to Li-Fraumeni syndrome, a highly penetrant familial cancer phenotype typically associated with inherited mutations in TP53. These mutations are also thought to confer predisposition to other types of cancer. The described mouse monoclonal IgG1 antibody binds to human Chk2 and has been described for use in immunoprecipitation and western blot.

*Abstract: Mouse monoclonal antibody (clone 4B8) against the human Serine/threonine-protein kinase Chk2. This antibody has been tested for use in immunoprecipitation and western blot.

*Principal Investigation: Name: Eva Y H P Lee
Department:

其他

Related Materials

Direct Activation of ATM by Resveratrol under Oxidizing Conditions
A novel synthetic protoapigenone analogue, WYC02-9, induces DNA damage and apoptosis in DU145 prostate cancer cells through generation of reactive oxygen species.

Additional Technologies by these Inventors

Tech ID/UC Case

25191/2011-382-0

Related Cases

2011-382-0, 2011-086-0, 2011-375-0, 2011-376-0, 2011-377-0, 2011-378-0, 2011-379-0, 2011-380-0, 2011-381-0, 2011-383-0, 2011-384-0, 2011-385-0, 2011-386-0, 2011-387-0

國家/地區: 美國

欲了解更多信息，請點擊這裡